Mitoquinone mesylate is primarily used in research focused on mitochondrial function and oxidative stress. It is a mitochondria-targeted antioxidant that helps protect cells from damage caused by reactive oxygen species (ROS). This compound is particularly valuable in studies related to aging, neurodegenerative diseases, and conditions where mitochondrial dysfunction plays a key role. Researchers utilize it to investigate potential therapeutic strategies for diseases like Alzheimer's, Parkinson's, and cardiovascular disorders. Additionally, it has shown promise in enhancing cellular energy production and reducing inflammation, making it a subject of interest in both preclinical and clinical studies. Its ability to selectively accumulate in mitochondria allows for targeted intervention, offering insights into mitochondrial biology and potential treatments for mitochondrial-related diseases.